Neurocrine Biosciences (NasdaqGS:NBIX) Q2 2026 Earnings call July 30, 2026 04:30 PM ET Company ParticipantsTodd Tushla - VP of Investor RelationsKyle Gano - CEOMatt Abernethy - CFOEric Benevich - Chief Commercial OfficerSanjay Keswani - Chief Medical OfficerSamir Siddhanti - Chief Business OfficerConference Call ParticipantsPaul Matteis - AnalystPhil Nadeau - AnalystTazeen Ahmad - AnalystBrian Skorney - AnalystMohit Bansal - AnalystAnupam Rama - AnalystCory Kasimov - AnalystJay Olson - AnalystAkash Tewari - ...